These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2323221)

  • 1. Histological changes in the vas deferens of rats after injection of a new male antifertility agent "SMA" and its reversibility.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1990 Mar; 41(3):333-9. PubMed ID: 2323221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety evaluation of a male injectable antifertility agent, styrene maleic anhydride, in rats.
    Sethi N; Srivastava RK; Singh RK
    Contraception; 1989 Feb; 39(2):217-26. PubMed ID: 2706990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-controlled injectable occlusion of the vas deferens.
    Guha SK; Anand S; Ansari S; Farooq A; Sharma DN
    Contraception; 1990 Mar; 41(3):323-31. PubMed ID: 2323220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive.
    Verma K; Misro MM; Singh H; Mahajan S; Ray AR; Guha SK
    J Reprod Fertil; 1981 Nov; 63(2):539-42. PubMed ID: 7299756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats.
    Koul V; Srivastav A; Guha SK
    Contraception; 1998 Oct; 58(4):227-31. PubMed ID: 9866004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical toxicity study of a male injectable antifertility agent (styrene maleic anhydride) in rhesus monkeys, Macaca mulatta.
    Sethi N; Srivastava RK; Nath D; Singh RK
    J Med Primatol; 1991; 20(2):89-93. PubMed ID: 1865485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical trial of an injectable contraceptive for the male.
    Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
    Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
    Guha SK
    Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception.
    Ansari AS; Hussain M; Khan SR; Lohiya NK
    Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural changes in the vas deferens of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride and after its reversal.
    Manivannan B; Mishra PK; Lohiya NK
    Contraception; 1999 Feb; 59(2):137-44. PubMed ID: 10361629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive.
    Guha SK
    Asian J Androl; 2007 Mar; 9(2):221-7. PubMed ID: 17334590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal.
    Lohiya NK; Suthar R; Khandelwal A; Goyal S; Ansari AS; Manivannan B
    Int J Androl; 2010 Feb; 33(1):e198-206. PubMed ID: 19811546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term toxicity studies of styrene maleic anhydride in rats.
    Sethi N; Srivastava RK; Singh RK; Nath D
    Biomed Environ Sci; 1990 Dec; 3(4):452-7. PubMed ID: 2096850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratological evaluation of an injectable male antifertility agent, styrene maleic anhydride, in rats.
    Sethi N; Srivastava RK; Nath D; Singh RK
    Int J Fertil; 1992; 37(3):183-7. PubMed ID: 1355766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-vas deferens injection of styrene maleic anhydride gel for male contraception: is it safe?
    Singh AK
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):208-9. PubMed ID: 12419065
    [No Abstract]   [Full Text] [Related]  

  • 17. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.
    Guha SK; Ansari S; Anand S; Farooq A; Misro MM; Sharma DN
    Contraception; 1985 Jul; 32(1):109-18. PubMed ID: 4053602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of genotoxicity in leukocytes and testis following intra-vasal contraception with RISUG and its reversal by DMSO and NaHCO₃ in Wistar albino rats.
    Ansari AS; Alam I; Hussain M; Khan SR; Lohiya NK
    Reprod Toxicol; 2013 Apr; 36():53-9. PubMed ID: 23246611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable non-occlusive chemical contraception in the male-I.
    Misro M; Guha SK; Singh H; Mahajan S; Ray AR; Vasudevan P
    Contraception; 1979 Nov; 20(5):467-73. PubMed ID: 43211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys.
    Lohiya NK; Manivannan B; Mishra PK
    Int J Androl; 2000 Feb; 23(1):36-42. PubMed ID: 10632760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.